75F40124F19001↗
Vets Synergetic Group LLC received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $3.19M obligated so far for support- management: other. It runs to 2027-07-23.
Key facts · data as of Oct 25, 2026
- Recipient
- Vets Synergetic Group LLC
- Awarding agency
- Food and Drug Administration (Department of Health and Human Services)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Obligated to date
- $3.19M
- Potential value
- $3.22M
- Ends
- 2027-07-23
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75F40124F19001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75F40124F19001_7524_75F40124D00020_7524
Vets Synergetic Group LLC: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys · The follow-on: recompete brief
TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020.
Up for re-bid: ends 2027-07-23. Recompete brief →
What it is
- Product or service
- Support- Management: Other (PSC R799)
- Industry
- All Other Professional, Scientific, and Technical Services (NAICS 541990)
- Contracting office
- Fda Office of Acq Grant Svcs (75F401)
- Competition
- Competed under simplified acquisition
- Pricing
- Labor hours
- How it was bought
- Single-award IDIQ · under 75F40124D00020
- Where the work is
- Montgomery, MD · district MD-08
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
6 actions since 2024-07-02. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-18 | P00005 | Option exercised | $745.0K | TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS-EXERCISE OP2 AND MODIFY OP2 POP. |
| 2026-04-14 | P00004 | Administrative change | $0 | TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS. |
| 2025-07-21 | P00003 | Option exercised | $1.14M | MODIFICATION TO CHANGE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2025 AND EXERCISE OY1 |
| 2024-12-10 | P00002 | Administrative change | $0 | NO COST MODIFICATION TO CHANGE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2025. |
| 2024-11-04 | P00001 | Administrative change | $0 | NO COST MODIFICATION TO CHANGE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2025. |
| 2024-07-02 | 0 | $1.31M | TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗